Pro Health Topics
result(s)
-
-
Long-Term Efficacy and Safety Results from the Phase 3 ERASURE and FIXTURE Trials of secukinumab in Psoriasis
-
The Impact of Diet and Physical Activity on Psoriasis
-
Efficacy and Safety Results from the Phase 3 POETYK PSO-1 trial of deucravacitinib versus Placebo and apremilast in Moderate-to-Severe Plaque Psoriasis
-
The US Food and Drug Administration Approves deucravacitinib (Sotyktu) for Oral Treatment of Moderate-to-Severe Plaque Psoriasis in Adults
